{"donor_id":"CPCG0001","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"69","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0003","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0006","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"73","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.40","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0009","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"77","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0020","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 16.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0040","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0046","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"79","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0047","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 13.20","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0048","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"74","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0057","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0063","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"68","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.80","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0073","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0078","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0081","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"75","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 17.80","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0083","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 12.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0087","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"72","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.40","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0094","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"77","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 16.41","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0095","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"68","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0098","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"80","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0099","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.96","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0102","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"58","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.65","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0114","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"67","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.40","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0117","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0121","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.20","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0123","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.80","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0124","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"72","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.20","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0127","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"54","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 29.90","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0128","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 30.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0154","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"55","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 13.80","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0158","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0166","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"74","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.80","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0182","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.64","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0183","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"64","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.67","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0184","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"51","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.53","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0185","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.49","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0189","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.52","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0190","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"74","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0191","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 11.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0196","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"52","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.88","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0199","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"74","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0201","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 1.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0203","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 2.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0205","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"64","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 20.40","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0206","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0208","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0210","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"51","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.51","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0211","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"75","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0212","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0213","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"67","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0217","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0232","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.15","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0233","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.63","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0234","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0236","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.92","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0238","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"55","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.92","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0241","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.64","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0242","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"56","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0246","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.64","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0248","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"54","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0249","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0250","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.23","_project_id":"PRAD-CA"}
